Airbus Joins Air India A320 Altitude Drop Probe 
Brazil Supreme Court Tightens Jair Bolsonaro House Arrest Ahead of Election 
Maduro U.S. Drug Trafficking Trial Set for June 2027 as Immunity Defense Looms 
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak 
AI Avatar of Jair Bolsonaro Sparks Legal Battle Ahead of Brazil’s 2026 Presidential Election 
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Juan Orlando Hernandez Seeks Dismissal of Honduras Charges After Trump Pardon 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 
New Mexico Sues DOJ Over Unredacted Jeffrey Epstein Files Amid Ongoing Investigation 
Australia’s health regulator, the Therapeutic Goods Administration (TGA), has launched legal action against News Corp Australia-owned News Life Media, Mamamia.com.au, AG Therapeutics, and public relations firm Straight Up PR for allegedly breaching medicinal cannabis advertising laws.
The TGA is seeking financial penalties, claiming the companies unlawfully advertised prescription-only cannabis products, violating the Therapeutic Goods Act 1989. The Act strictly prohibits the promotion of prescription medicines, including medicinal cannabis, to the public without prior authorization.
According to the TGA, articles published by News Life Media and Mamamia featured illegal testimonials and endorsements from healthcare professionals and individuals associated with patients, which are banned under Australian advertising codes. The watchdog also accused AG Therapeutics of using euphemisms like “plant medicine” in its marketing while promoting cannabis as a treatment for serious health conditions across its website and social media platforms.
TGA head Anthony Lawler said the parties involved had previously received multiple warnings regarding the unlawful promotion of therapeutic goods. Despite these alerts, the alleged advertising continued.
News Corp Australia, a unit of global media giant News Corp (NASDAQ:NWSA), has not responded to media inquiries about the proceedings. The case highlights the growing scrutiny over cannabis advertising and the regulator’s commitment to enforcing compliance in the rapidly expanding medicinal cannabis sector.
The lawsuit signals a warning to media outlets, natural health brands, and PR firms engaging in unapproved promotions of prescription therapies. As cannabis becomes more mainstream in Australia, businesses are urged to align with legal frameworks to avoid regulatory penalties and reputational damage.
This case also emphasizes the importance of responsible marketing in the health and wellness industry, particularly when dealing with prescription-only products like medicinal cannabis.
